Are you a veterinarian with a passion for clinical trials? We're looking for an experienced Clinical Development Veterinarian to join our team. In this role, you'll have the opportunity to be hands on with the medical monitoring of our trials, the veterinarians involved, and crafting communications with the FDA. If you want to be on the front lines of bringing the first FDA-approved dog longevity drugs to veterinary clinics and dog owners nationwide, we'd love to hear from you. Apply here → https://lnkd.in/g6r8FzWR
Loyal
Biotechnology Research
San Francisco, CA 13,073 followers
Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs.
About us
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to help dogs everywhere.
- Website
-
http://loyal.com
External link for Loyal
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Francisco, CA
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
San Francisco, CA 94103, US
Employees at Loyal
-
Elaine Zhou
CPTO, Technology & Product Leader | Advisor & Speaker | Transforming Business Through AI Innovation
-
Mai Tran
Medical and Clinical Programs Strategy | Oncology Clinical Research | Cross-functional Lead
-
Sidney Miller
-
John Ayres
Corporate Counsel / Business and Legal Advisor
Updates
-
From early conversations around a campfire that led to our founding all the way to our work today and vision for the future, hear Founder & CEO Celine Halioua cover everything Loyal on The Room Podcast with Claudia Laurie and Madison McIlwain: https://lnkd.in/gvNYwz9S
-
-
🚨 New publication in JAVMA 🚨 “Aging is modifiable: Current perspectives on healthy aging in companion dogs and cats” is an open-access paper that challenges the notion that aging is inevitable. Explore how advancing our understanding of aging can help extend healthspan and quality of life in pets — and give more time to our best friends. Read more → https://lnkd.in/ganUzdMG
-
-
Loyal reposted this
Discover the science behind extending your patients’ healthy years. Join us for a deep dive into the biology of canine aging and explore how preventive interventions can delay disease and preserve quality of life. Earn 1 RACE-approved CE credit. Sponsored by: Loyal Register: https://hubs.li/Q03MwH1V0 #vetmed #preventivecare #veterinaryCE
-
-
Ever wondered how our Founder & CEO Celine Halioua thinks about drug development, AI, and the future of longevity? She sat down with Jordi Hays and John Coogan from TBPN yesterday to unpack it all. Tune in at 1:56 to hear the scoop: https://lnkd.in/gEXQMBuq
Monday, October 6th
https://www.youtube.com/
-
Loyal reposted this
Why do bigger dogs have shorter lifespans? Celine Halioua, founder and CEO of dog longevity company Loyal, explains how understanding why is key to treatments that help them live longer.
-
Are you obsessed with analytical methods and data interpretation with a keen sense for technical analysis? We're looking for a Senior Scientist to join our CMC Analytical team. In this role, you'll have the opportunity to serve as the SME and work on the review and interpretation of analytical data across release and stability programs. If you want to have a hands-on role in the interpreting critical CMC data and crafting actionable insights for the world's first longevity drugs for dogs, we'd love to hear from you. Apply here → https://lnkd.in/gWwGQp2k
-
-
We're seeking a Head of Regulatory CMC to join our team! In this role, you'll be an integral leader within Loyal's regulatory CMC function, managing all related documents and dossiers to the FDA for LOY-002 and our portfolio of longevity drugs. If you're a detail-oriented writer and sharp regulatory advisor with a proven track record of successful work with the FDA and CVM, we'd love to hear from you. Apply here → https://lnkd.in/g4B_u6rn
-
-
Are you a strong leader with a proven track record of driving cross-functional collaboration and R&D program strategies to success? We're seeking a Senior Director, Program Management, to join our team. In this role, you'll have the unique opportunity to work closely with our executive team and help guide our programs through the FDA approval process and portfolio expansion. If you're a creative thinker and effective communicator with experience with managing drug programs from discovery through commercialization, we'd love to hear from you. Apply here → https://lnkd.in/gNJZUAsf
-
-
We’re seeking a Chief Technical Operations Officer to lead our drug candidate manufacturing and the scale up of our portfolio from R&D through commercial launch. This is a unique opportunity to bring first-principles leadership, deep technical expertise, and operational excellence to a team tackling one of biotech’s most ambitious goals. If you’re a low-ego leader with strategic experience bringing drug products from discovery to commercialization, we’d love to hear from you. Apply now → https://lnkd.in/gBnzhf5P
-